Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Value of cannabidiol as adjunctive treatment for Lennox Gastaut syndrome: cost-effectiveness and budget impact analysis

Original Submission
17 Sep 2024 Submitted Original manuscript
31 Oct 2024 Reviewed Reviewer Report - Nicholas Aderinto
18 Nov 2024 Reviewed Reviewer Report - Dezhi Cao
2 Dec 2024 Author responded Author comments - Khosro Keshavarz
5 Dec 2024 Reviewed Reviewer Report - Nicholas Aderinto
8 Feb 2025 Reviewed Reviewer Report - Dezhi Cao
26 Feb 2025 Author responded Author comments - Khosro Keshavarz
Resubmission - Version 2
2 Dec 2024 Submitted Manuscript version 2
Publishing
26 Feb 2025 Editorially accepted
5 Mar 2025 Article published 10.1186/s12916-025-03972-9

You can find further information about peer review here.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us